Navigation Links
BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
Date:12/13/2007

SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the appointment of Richard I. Gilchrist to its board of directors, increasing the board to eight members.

"Rick is a proven leader in the real estate industry, with a breadth of ability and experience in the acquisition, financing, development and operation of large-scale commercial real estate projects. We believe that Rick's contributions to our Board will be invaluable as we continue to execute on our growth strategy of selective acquisition and development of well- located, world-class life science properties," said Alan D. Gold, President and Chief Executive Officer of BioMed Realty Trust.

Mr. Gilchrist is President of the Investment Properties Group for The Irvine Company, a privately held real estate investment company, where he guides all aspects of The Irvine Company's office, retail, resort and apartment properties in Orange County, Los Angeles, San Diego and the Silicon Valley, including development, marketing and management. Prior to joining The Irvine Company in 2006, Mr. Gilchrist served as President and Co-Chief Executive Officer and on the board of directors of Maguire Properties, Inc., a publicly held real estate investment trust (REIT). At Maguire, he oversaw significant growth in the company's portfolio, both through acquisitions and development, and spearheaded the company's successful initial public offering in 2003. Before joining Maguire in 2001, Mr. Gilchrist served as Chief Executive Officer, President and member of the board of directors of Commonwealth Atlantic Properties, a privately held REIT, where he managed the planning and entitlement of one of the East Coast's largest and most complex mixed-used
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
5. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
6. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
7. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
8. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
9. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
10. Environmental Tectonics Corporations BioMedical Division Announces New Contract
11. Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 2015 , ... Knowledgent , the data and analytics firm, today announced ... data lakes in the healthcare industry. , As the Internet of Things (IoT) continues ... the last few years as more entities become technology enabled through Electronic Medical Records ...
(Date:9/1/2015)... ... September 01, 2015 , ... GenoCAD, a leading ... new version of its flagship DNA design platform, which has been enhanced to ... into numerous genetic parts, which in turn can be recombined using specific sets ...
(Date:8/31/2015)... , Aug. 31, 2015 MabVax Therapeutics Holdings, ... announces that the Company,s lead antibody, HuMab 5B1, will ... separate presentations during the upcoming World Molecular Imaging Congress ... September 2-5, 2015. Researchers from the Department of Radiology ... results on the use of MabVax,s lead antibody as ...
(Date:8/31/2015)... Aug. 31, 2015  For people with Down syndrome, ... day. The biotechnology company, located in the Science + ... the best potential therapies yet for people with Down syndrome ... Correction of Down syndrome and Edwards syndrome aneuploidies in ... DNA Research . Elixirgen plans to develop this technology ...
Breaking Biology Technology:New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 3MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 4New Down syndrome therapy discovered 2
... a new detector so sensitive it can pick up a ... create the sensors, chemical engineers led by Michael Strano coated ... with protein fragments normally found in bee venom. This ... react to explosives, specifically a class known as nitro-aromatic compounds ...
... May 9, 2011 Data from a Phase ... with REMICADE® (infliximab) in the treatment of pediatric ... (UC), and showed a safety profile consistent with ...  The pediatric UC findings, presented today at Digestive ...
... 9, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. ... "AOB"), a pharmaceutical company dedicated to improving health ... broad range of prescription and over–the-counter ("OTC") products, ... ended March 31, 2011. First ...
Cached Biology Technology:MIT news: New sensor can detect tiny traces of explosives 2MIT news: New sensor can detect tiny traces of explosives 3New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 2New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 3New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 4New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 5New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 6New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 7New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis 8American Oriental Bioengineering Reports First Quarter 2011 Financial Results 2American Oriental Bioengineering Reports First Quarter 2011 Financial Results 3American Oriental Bioengineering Reports First Quarter 2011 Financial Results 4American Oriental Bioengineering Reports First Quarter 2011 Financial Results 5
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... MA Current research suggests that lowering cholesterol may block ... Solomon et al, "Ezetimibe Is an Inhibitor of Tumor Angiogenesis," ... Journal of Pathology . High cholesterol not only leads ... cancer growth and progression. Prostate cancer is the most ...
... team of European scientists have finally solved a mystery that has ... notion that gray hair is a sign of wisdom, these researchers ... Journal ( http://www.fasebj.org ) that wisdom has nothing to do ... of hydrogen peroxide due to wear and tear of our hair ...
... Great Ape Trust of Iowa scientist Dr. Serge Wich ... a book set for release in the United States ... collected at every known orangutan research site and examines ... species, subspecies and populations. Scientists are aware of significant ...
Cached Biology News:Lowering your cholesterol may decrease your risk of cancer 2No longer a gray area: Our hair bleaches itself as we grow older 2New book expands field data available on orangutans 2New book expands field data available on orangutans 3
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
... ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C 14 ... N O 6 ,M.W.= 408.63 ... Clear (2% in DMF) ,Biological Activity: ... M13 ,Elemental Analysis: Agrees with theoretical ...
... new D-LUX Detection Platform combines robust ... the most sensitive, specific, and cost-effective ... D-LUX Detection Platform offers exceptional performance ... TaqMan probes, high signal/background ratio, and ...
Based on Silica membrane matrix beads. The kit is designed for the purification of DNA (20 bp - 100 bp) from TAE/TBE agarose gels. Run time is approximately 45 minutes....
Biology Products: